Heavily outsources clinical trial activities to third-party CROs

{
  "signal_id": "90ed0126-82dc-4045-8ead-865c1b7e1be9",
  "signal_type": "sec-10k",
  "signal_subtype": "supplierConcentration",
  "detected_at": "2026-03-03T05:50:03.57+00:00",
  "company": {
    "name": "Gilead",
    "domain": "gilead.com"
  },
  "data": {
    "detail": "Gilead extensively outsources its clinical trial activities, relying on third-party contract research organizations (CROs) for critical functions like site management, patient enrollment, and monitoring. This deep dependency creates a need for robust vendor management, data integration, and oversight solutions to mitigate operational risks.",
    "metrics": {
      "timeframe": "current_year"
    },
    "summary": "Heavily outsources clinical trial activities to third-party CROs",
    "excerpts": "We extensively outsource our clinical trial activities and usually perform only a small portion of start-up activities in-house. We rely on third-party contract research organizations to perform most of our clinical studies, including document preparation, site identification, screening and preparation, pre-study visits, training, program management, patient enrollment, ongoing monitoring, site management and bioanalysis.",
    "relevance": 0.8,
    "sentiment": "neutral",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/882095/000088209526000006/gild-20251231.htm",
    "filing_date": "2026-02-24",
    "filing_year": 2026,
    "fiscal_year_end": "12/31",
    "sales_relevance": "Risk management needed",
    "signal_category": "market"
  }
}

curl https://signals.autobound.ai/v1/signals/90ed0126-82dc-4045-8ead-865c1b7e1be9 \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"gilead.com","limit":20}'